Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Hauptverfasser: Rory Barry (Verfasst von), Gregg Murray (Verfasst von), Sally McGrath (Verfasst von), Clive Kilgallen (Verfasst von), Karen Eustace (Verfasst von)
• Format: Buch
• Veröffentlicht: Wiley, 2024-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...